Kelley Discusses Efficacy and Safety Considerations With the STRIDE Regimen in HCC
0
0
2 ভিউ·
08/31/23
Dr Kelley discusses standard first-line treatment options for patients with advanced HCC, key findings from the phase 3 HIMALAYA trial, and the safety profile of the STRIDE regimen in this population.
আরো দেখুন
0 মন্তব্য
sort ক্রমানুসার
